'Anti-Woke' 1789 Capital Bets on Drug Startup BlinkRx

Omeed Malik's 1789 Capital, featuring Donald Trump Jr., led a $140 million funding round for BlinkRx, a startup focused on affordable prescription medication. The firm invests in conservative-leaning companies like BlinkRx, which aims to make prescriptions accessible and affordable.